0001703057-24-000026.txt : 20240227
0001703057-24-000026.hdr.sgml : 20240227
20240227141258
ACCESSION NUMBER: 0001703057-24-000026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240226
FILED AS OF DATE: 20240227
DATE AS OF CHANGE: 20240227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hansen Carl L. G.
CENTRAL INDEX KEY: 0001834412
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 24685212
MAIL ADDRESS:
STREET 1: C/O ABCELLERA BIOLOGICS INC.
STREET 2: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbCellera Biologics Inc.
CENTRAL INDEX KEY: 0001703057
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
BUSINESS PHONE: (604) 559-9005
MAIL ADDRESS:
STREET 1: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
4
1
wk-form4_1709061178.xml
FORM 4
X0508
4
2024-02-26
0
0001703057
AbCellera Biologics Inc.
ABCL
0001834412
Hansen Carl L. G.
C/O ABCELLERA BIOLOGICS INC
2215 YUKON STREET
VANCOUVER
A1
BRITISH COLUMBIA, CANADA
1
1
1
0
Chief Executive Officer
0
Common Shares
2024-02-26
5
M
0
E
56125
2.70
A
729625
D
Common Shares
55802493
I
See footnote
Share option (right to buy)
2.70
2024-02-26
5
M
0
E
56125
0
D
2030-11-27
Common Shares
56125
8428598
D
These shares are held by Thermopylae Holdings Ltd., which is an entity wholly owned by the reporting person.
The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.
Tryn Stimart, attorney-in-fact
2024-02-27